- Home
- BKSY vs TNGX Comparison
BKSY vs TNGX Comparison
Compare BKSY & TNGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BKSY
- TNGX
- Stock Information
- Founded
- BKSY 2013
- TNGX 2014
- Country
- BKSY United States
- TNGX United States
- Employees
- BKSY N/A
- TNGX N/A
- Industry
- BKSY Radio And Television Broadcasting And Communications Equipment
- TNGX Biotechnology: Pharmaceutical Preparations
- Sector
- BKSY Technology
- TNGX Health Care
- Exchange
- BKSY Nasdaq
- TNGX Nasdaq
- Market Cap
- BKSY 643.3M
- TNGX 723.2M
- IPO Year
- BKSY N/A
- TNGX N/A
- Fundamental
- Price
- BKSY $18.14
- TNGX $7.29
- Analyst Decision
- BKSY Strong Buy
- TNGX Strong Buy
- Analyst Count
- BKSY 6
- TNGX 6
- Target Price
- BKSY $23.50
- TNGX $10.00
- AVG Volume (30 Days)
- BKSY 1.6M
- TNGX 1.5M
- Earning Date
- BKSY 11-06-2025
- TNGX 11-05-2025
- Dividend Yield
- BKSY N/A
- TNGX N/A
- EPS Growth
- BKSY N/A
- TNGX N/A
- EPS
- BKSY N/A
- TNGX N/A
- Revenue
- BKSY $104,662,000.00
- TNGX $24,296,000.00
- Revenue This Year
- BKSY $15.34
- TNGX $6.56
- Revenue Next Year
- BKSY $34.07
- TNGX N/A
- P/E Ratio
- BKSY N/A
- TNGX N/A
- Revenue Growth
- BKSY N/A
- TNGX N/A
- 52 Week Low
- BKSY $3.86
- TNGX $1.03
- 52 Week High
- BKSY $28.85
- TNGX $10.81
- Technical
- Relative Strength Index (RSI)
- BKSY 53.32
- TNGX 59.88
- Support Level
- BKSY $15.37
- TNGX $6.38
- Resistance Level
- BKSY $19.88
- TNGX $6.90
- Average True Range (ATR)
- BKSY 1.13
- TNGX 0.43
- MACD
- BKSY 0.34
- TNGX -0.00
- Stochastic Oscillator
- BKSY 66.81
- TNGX 90.43
About BKSY BlackSky Technology Inc.
BlackSky Technology Inc is a provider of real-time geospatial intelligence. The company delivers on-demand, high-frequency imagery, monitoring, and analytics of some of the critical and strategic locations, economic assets, and events in the world. It designs, owns, and operates one of the industry's low earth orbit (LEO) small satellite constellations, optimized to capture imagery cost-efficiently where and when its customers need it. its Spectra AI software platform processes data from BlackSky's constellation and other third-party sensors to develop the critical insights and analytics that provide its customers with the actionable intelligence. Geographically, the company operates in North America, the Middle East, Asia, and Others.
About TNGX Tango Therapeutics Inc.
Tango Therapeutics Inc is a biotechnology company. It is dedicated to discovering novel drug targets and delivering the next generation of precision medicine for the treatment of cancer. It is engaged in the business of discovering and developing precision oncology therapies. It is currently developing two MTA-cooperative PRMT5 inhibitors; TNG462 for non-CNS cancers, including pancreatic and lung cancer, and TNG456, a next-generation, brain-penetrant PRMT5 inhibitor, for CNS cancers, including GBM. Its pipeline products are PRMT5 and CoREST.